Osteoarthritis Drugs Market Size & Share 2024 - 2032
Market Size by Drug Type (Viscosupplementation Agents, NSAIDs, Analgesics, Corticosteroids), by Route of Administration (Oral, Parenteral), by Anatomy, by Medication.
Report ID: GMI8580
|
Published Date: March 2024
|
Report Format: PDF
Download Free PDF
Authors:
Mariam Faizullabhoy, Gauri Wani
Osteoarthritis Drugs Market Size
Osteoarthritis Drugs Market was valued at USD 8.9 billion in 2023 and is expected to reach USD 16.1 billion by end of 2032, growing at a CAGR of 6.9% over the analysis period. The industry is experiencing dynamic growth driven by factors such as increasing prevalence of osteoarthritis majorly among geriatric population and growing research & development activities for osteoarthritis therapeutics.
Osteoarthritis Drugs Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
According to the data published by Centers for Disease Control and Prevention in 2023, approximately 32.5 million people have osteoarthritis in the U.S. alone. Therefore, advancement in treatment of osteoarthritis and drug development, introduction of personalized osteoarthritis new medications and enhancing accessibility of therapeutics across various healthcare facilities is anticipated to accelerate the market growth.
Osteoarthritis drugs refer to pharmaceutical agents and medications specifically designed or prescribed to manage the symptoms and slow the progression of osteoarthritis, a degenerative joint disease characterized by the breakdown of cartilage in the joints. These drugs encompass various classes of medications. They work through different mechanisms to alleviate pain, reduce inflammation, improve joint function, and potentially modify the underlying disease process.
Osteoarthritis Drugs Market Trends
Osteoarthritis Drugs Market Analysis
Based on the drug type, the global market is classified into viscosupplementation agents, nonsteroidal anti-inflammatory drugs, analgesics, corticosteroids, and other drug types. The viscosupplementation agents drug type segment dominated the market with revenue of USD 3 billion in 2023.
Based on route of administration, the osteoarthritis drugs market is classified into oral, parenteral, topical. The parenteral segment held highest market share of 41.5% in 2023.
Based on anatomy, the osteoarthritis drugs industry is classified into ankle osteoarthritis, hip osteoarthritis, knee osteoarthritis, shoulder osteoarthritis, and other anatomies. The knee osteoarthritis segment is expected to hold the highest revenue throughout the forecast period.
Based on medication, the osteoarthritis drugs market is classified into prescription and over-the-counter (OTC) drugs. The over-the-counter segment held highest share of 56.7% in 2023.
Based on distribution channel, the market is classified into hospital pharmacies, retail pharmacies, and online pharmacy. The hospital pharmacies segment held the highest CAGR of 7.2% over forecast period.
In 2023, North America secured a substantial market share of 41.1% in 2023 and is expected to dominate throughout the forecast period.
Osteoarthritis Drugs Market Share
The competitive landscape of the osteoarthritis drugs industry is characterized by the presence of established companies vying for market share. Key players are engaging in strategic initiatives such as mergers, acquisitions, and partnerships to strengthen their product portfolios. The companies are actively adopting a multi-pronged approaches to address the rising demand for effective osteoarthritis drugs.
Osteoarthritis Drugs Market Companies
Prominent players operating in the market are as mentioned below:
Osteoarthritis Drugs Industry News:
The osteoarthritis drugs market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 - 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Drug Type
Market, By Route of Administration
Market, By Anatomy
Market, By Medication
Market, By Distribution Channels
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →